Celon Pharma S.A. (FRA:8RP)

Germany flag Germany · Delayed Price · Currency is EUR
4.845
+0.040 (0.83%)
Last updated: Dec 5, 2025, 8:18 AM CET
-19.38%
Market Cap 272.87M
Revenue (ttm) 52.87M
Net Income (ttm) -28.68M
Shares Out n/a
EPS (ttm) -0.55
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 1
Open 4.845
Previous Close 4.805
Day's Range 4.845 - 4.845
52-Week Range 4.440 - 6.650
Beta n/a
RSI 50.50
Earnings Date Nov 19, 2025

About Celon Pharma

Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. operates as a subsidiary of Glatton Sp. z o.o. [Read more]

Industry Pharmaceutical Preparations
Founded 2002
Employees 558
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 8RP
Full Company Profile

Financial Performance

In 2024, Celon Pharma's revenue was 205.55 million, a decrease of -4.25% compared to the previous year's 214.66 million. Losses were -34.45 million, 22.5% more than in 2023.

Financial numbers in PLN Financial Statements

News

There is no news available yet.